Top Markets
Coin of the day
Axcella Health Inc. Axcella Health Inc.

Axcella Health Inc.

AXLA
Rang in aandelen #18692
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused... Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.
Aandeelprijs
$4.58
Laatst gesynchroniseerd: 2025-02-06
Marktkapitalisatie
$189.73M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Axcella Health Inc. (AXLA)

Categorie

Koersgeschiedenis voor Axcella Health Inc. (AXLA)
Hoogste slotkoers: $4.58 op 2025-02-01

Laagste slotkoers: $350.75 op 2019-05-01
Koersgeschiedenis van Axcella Health Inc. van 2019 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 0.00%
2024 512.21%
2023 -94.99%
2022 -75.57%
2021 -55.79%
2020 46.98%
2019 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$549.38 41.89%
US
$1.05K 47.72%
NL
$148.35 499.86%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH